Published in J Natl Med Assoc on July 01, 2007
Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA (2008) 3.53
Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst (2010) 3.16
Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol (2012) 1.65
Disparities in colorectal cancer in African-Americans vs Whites: before and after diagnosis. World J Gastroenterol (2009) 1.55
Risk of colorectal cancer among Caucasian and African American veterans with ulcerative colitis. Inflamm Bowel Dis (2011) 1.53
Does level of sedation impact detection of advanced neoplasia? Dig Dis Sci (2010) 1.48
Racial disparities in advanced-stage colorectal cancer survival. Cancer Causes Control (2013) 1.10
Clinicopathological features of colon polyps from African-Americans. Dig Dis Sci (2010) 1.06
Racial disparity in death from colorectal cancer: does vitamin D deficiency contribute? Cancer (2010) 1.04
Factors associated with colon cancer stage at diagnosis. Dig Dis Sci (2009) 1.04
Screening for colorectal cancer: possible improvements by risk assessment evaluation? Scand J Gastroenterol (2011) 0.99
Ethnic and sex disparities in colorectal neoplasia among Hispanic patients undergoing screening colonoscopy. Clin Gastroenterol Hepatol (2012) 0.98
A black-white comparison of the quality of stage-specific colon cancer treatment. Cancer (2010) 0.93
Importance of pre-transplant colonoscopy in renal transplant recipients. J Clin Med Res (2014) 0.91
Prevalence and distribution of adenomas in black Americans undergoing colorectal cancer screening. Dig Dis Sci (2011) 0.91
Excess of proximal microsatellite-stable colorectal cancer in African Americans from a multiethnic study. Clin Cancer Res (2014) 0.90
Racial differences in colorectal cancer incidence and mortality in the Women's Health Initiative. Cancer Epidemiol Biomarkers Prev (2011) 0.89
Screening options and recommendations for colorectal cancer. Clin Colon Rectal Surg (2009) 0.89
Associations between markers of colorectal cancer stem cells and adenomas among ethnic groups. Dig Dis Sci (2012) 0.86
Determinants of polyp size in patients undergoing screening colonoscopy. BMC Gastroenterol (2011) 0.86
Factors that increase risk of colon polyps. Clin Colon Rectal Surg (2008) 0.86
Protective association of colonoscopy against proximal and distal colon cancer and patterns in interval cancer. Gastrointest Endosc (2015) 0.85
Colorectal neoplasia detection among black and Latino individuals undergoing screening colonoscopy: a prospective cohort study. Gastrointest Endosc (2014) 0.82
Screening Colonoscopy among Uninsured and Underinsured Urban Minorities. Gut Liver (2015) 0.81
Trends in colorectal cancer among hispanics by stage and subsite location: 1989-2006. Clin Transl Gastroenterol (2012) 0.79
Race and Prevalence of Large Bowel Polyps Among the Low-Income and Uninsured in South Carolina. Dig Dis Sci (2015) 0.79
Higher prevalence of proximal colon polyps and villous histology in African-Americans undergoing colonoscopy at a single equal access center. J Gastrointest Oncol (2015) 0.78
Colorectal cancer screening in African Americans: practice patterns in the United States. Are we doing enough? Gastroenterol Rep (Oxf) (2016) 0.78
Colonoscopy screening rates among patients of colonoscopy-trained African American primary care physicians. Cancer (2011) 0.78
The association of age and race and the risk of large bowel polyps. Cancer Epidemiol Biomarkers Prev (2014) 0.77
Trout ova, an alternative source of anti-B. Med Lab Sci (1976) 0.75
Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma. Leuk Lymphoma (2015) 0.75
Racial Differences in Stage IV Colorectal Cancer Survival in Younger and Older Patients. Clin Colorectal Cancer (2016) 0.75
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Cancer statistics, 2005. CA Cancer J Clin (2005) 25.65
Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med (1993) 21.18
Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology (2003) 14.67
Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med (2000) 13.21
Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med (1997) 8.25
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst (2003) 7.06
Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med (2000) 6.90
Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med (2002) 5.97
The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer (2000) 4.89
Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. J Natl Cancer Inst (2000) 4.20
The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology (1990) 3.72
Colorectal cancer in African Americans. Am J Gastroenterol (2005) 3.18
Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med (2004) 3.18
Meat consumption and risk of colorectal cancer. JAMA (2005) 3.15
Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst (1995) 2.36
The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer (1997) 2.35
Screening colonoscopy in asymptomatic average-risk African Americans. Gastrointest Endosc (2000) 1.65
Cigarette smoking and colorectal carcinoma mortality in a cohort with long-term follow-up. Cancer (2004) 1.59
Patterns of endoscopy use in the United States. Gastroenterology (2000) 1.59
Gender differences in colorectal polyps and tumors. Am J Gastroenterol (2001) 1.35
Distribution of adenomatous polyps in African-Americans. Am J Gastroenterol (1995) 1.30
Racial differences in the anatomical distribution of colon cancer. Arch Surg (1992) 1.20
Height, weight, and alcohol consumption in relation to the risk of colorectal cancer in Japan: a prospective study. Br J Cancer (2003) 1.18
Lifetime cigarette smoking and colorectal cancer incidence in the Physicians' Health Study I. J Natl Cancer Inst (2000) 0.98
Alcohol consumption and colon and rectal cancer in postmenopausal women. Int J Epidemiol (1994) 0.93
Ethnic differences in the anatomical location of colorectal adenomatous polyps. Int J Cancer (1991) 0.91
Incidence of colorectal adenocarcinoma by anatomic subsite. An epidemiologic study of time trends and racial differences in the Detroit, Michigan area. Cancer (1997) 0.91
Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med (2002) 11.38
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2013) 5.56
Hospital lymph node examination rates and survival after resection for colon cancer. JAMA (2007) 4.55
PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma. N Engl J Med (2014) 3.86
Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma. J Clin Oncol (2011) 3.40
American Cancer Society lung cancer screening guidelines. CA Cancer J Clin (2013) 3.16
The genetic landscape of mutations in Burkitt lymphoma. Nat Genet (2012) 3.03
Follicular lymphoma in the United States: first report of the national LymphoCare study. J Clin Oncol (2009) 2.95
Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis. Hepatology (2005) 2.91
Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst (2005) 2.91
Race and surgical mortality in the United States. Ann Surg (2006) 2.31
Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood (2010) 2.15
Costs and effectiveness of genomic testing in the management of colorectal cancer. Oncology (Williston Park) (2015) 2.11
Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors. Blood (2004) 2.04
Hospital factors and racial disparities in mortality after surgery for breast and colon cancer. J Clin Oncol (2009) 2.02
Socioeconomic status and surgical mortality in the elderly. Med Care (2008) 2.01
Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States. Leuk Lymphoma (2008) 1.85
Surgeon and hospital characteristics as predictors of major adverse outcomes following colon cancer surgery: understanding the volume-outcome relationship. Arch Surg (2007) 1.73
Early discharge and hospital readmission after colectomy for cancer. Dis Colon Rectum (2011) 1.56
Poor survival after liver retransplantation: is hepatitis C to blame? Liver Transpl (2003) 1.52
Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis. Int J Radiat Oncol Biol Phys (2005) 1.40
Interferon alpha 2b and ribavirin for the treatment of recurrent hepatitis C after liver transplantation: cohort study of 38 patients. J Gastroenterol Hepatol (2005) 1.39
Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer (2010) 1.38
Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry. Liver Int (2007) 1.30
A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding study. Clin Cancer Res (2010) 1.29
Multicenter randomized phase II study of weekly or twice-weekly bortezomib plus rituximab in patients with relapsed or refractory follicular or marginal-zone B-cell lymphoma. J Clin Oncol (2009) 1.24
Racial clustering and access to colorectal surgeons, gastroenterologists, and radiation oncologists by African Americans and Asian Americans in the United States: a county-level data analysis. Arch Surg (2009) 1.21
Incidence and survival patterns of cutaneous T-cell lymphomas in the United States. Leuk Lymphoma (2013) 1.21
Surgical complications are associated with omission of chemotherapy for stage III colorectal cancer. Dis Colon Rectum (2010) 1.19
Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States. Clin Lymphoma Myeloma Leuk (2011) 1.11
Incidence patterns and outcomes for hodgkin lymphoma patients in the United States. Adv Hematol (2010) 1.08
Shared decision-making for cancer care among racial and ethnic minorities: a systematic review. Am J Public Health (2013) 1.07
A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma. ISRN Hematol (2011) 1.04
Insurance status is related to diffuse large B-cell lymphoma survival. Cancer (2014) 1.04
Practical approach for using Medicare data to estimate costs for cost-effectiveness analysis. Expert Rev Pharmacoecon Outcomes Res (2005) 1.04
Analytic morphometric assessment of patients undergoing colectomy for colon cancer. J Surg Oncol (2013) 1.02
Effectiveness and cost analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics. Transfusion (2011) 1.01
Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population. BMC Health Serv Res (2009) 1.01
Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology (2012) 1.01
Guideline-concordant cancer care and survival among American Indian/Alaskan Native patients. Cancer (2014) 0.98
The personal financial burden of complications after colorectal cancer surgery. Cancer (2014) 0.97
Characteristics and outcomes of diffuse large B-cell lymphoma presenting in leukaemic phase. Br J Haematol (2012) 0.96
Development of query strategies to identify a histologic lymphoma subtype in a large linked database system. Cancer Inform (2007) 0.94
Surveillance computed tomography scans for patients with lymphoma: is the risk worth the benefits? Clin Lymphoma Myeloma Leuk (2010) 0.93
Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience. Biol Blood Marrow Transplant (2007) 0.93
Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes. Blood (2010) 0.93
Perceived and actual quality of life with ulcerative colitis: a comparison of medically and surgically treated patients. Am J Gastroenterol (2011) 0.92
Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trials. Cancer (2013) 0.92
Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysis. J Clin Oncol (2013) 0.91
Pharmacokinetic-directed high-dose busulfan combined with cyclophosphamide and etoposide results in predictable drug levels and durable long-term survival in lymphoma patients undergoing autologous stem cell transplantation. Biol Blood Marrow Transplant (2012) 0.91
Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci. Am J Epidemiol (2015) 0.91
Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study. Cancer (2012) 0.89
Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome. Liver Transpl (2006) 0.88
Does surgeon case volume influence nonfatal adverse outcomes after rectal cancer resection? J Am Coll Surg (2008) 0.87
Diffuse large B-cell lymphoma: current treatment approaches. Oncology (Williston Park) (2012) 0.87
Development of the Lymphoma Enterprise Architecture Database: a caBIG Silver level compliant system. Cancer Inform (2009) 0.87
Bowel preparation for colectomy and risk of Clostridium difficile infection. Dis Colon Rectum (2011) 0.87
Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare Study. Cancer (2013) 0.87
Hepatitis C reactivation in patients who have diffuse large B-cell lymphoma treated with rituximab: a case report and review of literature. Clin Lymphoma Myeloma Leuk (2011) 0.86
The effect of care setting in the delivery of high-value colon cancer care. Cancer (2014) 0.86
Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin lymphoma. Clin Lymphoma Myeloma Leuk (2013) 0.85
Using primary site as a predictor of survival in mantle cell lymphoma. Cancer (2013) 0.84
Initial management strategies for follicular lymphoma. Int J Hematol Oncol (2012) 0.84
Racial disparities in esophageal cancer outcomes. Ann Surg Oncol (2012) 0.83
Identification of consensus-based quality end points for colorectal surgery. Dis Colon Rectum (2012) 0.83
Residence proximity to benzene release sites is associated with increased incidence of non-Hodgkin lymphoma. Cancer (2013) 0.83
To Each Its Own: Linking the Biology and Epidemiology of NHL Subtypes. Curr Hematol Malig Rep (2015) 0.83
A composite measure of personal financial burden among patients with stage III colorectal cancer. Med Care (2014) 0.82
Individual health discount rate in patients with ulcerative colitis. Inflamm Bowel Dis (2010) 0.82
Proximity to disease and perception of utility: physicians' vs patients' assessment of treatment options for ulcerative colitis. Dis Colon Rectum (2011) 0.82
Evaluating patients undergoing colorectal surgery to estimate and minimize morbidity and mortality. Surg Clin North Am (2012) 0.82
Risk of cytomegalovirus disease in high-risk liver transplant recipients on valganciclovir prophylaxis: a systematic review and meta-analysis. Liver Transpl (2012) 0.81
Patterns of social support among lymphoma patients considering stem cell transplantation. Soc Work Health Care (2011) 0.81
Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia. Support Care Cancer (2013) 0.80
Clinical, molecular, and environmental risk factors for hodgkin lymphoma. Adv Hematol (2010) 0.80
Treatment Strategies for Patients with Diffuse Large B-Cell Lymphoma: Past, Present, and Future. Blood Lymphat Cancer (2012) 0.80
Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease. Transfusion (2010) 0.80
ACR Appropriateness Criteria Pediatric Hodgkin Lymphoma. Pediatr Blood Cancer (2014) 0.80
The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States. Cancer (2014) 0.80
Transplantation in the alcoholic patient. Semin Liver Dis (2004) 0.80
Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States. Leuk Lymphoma (2014) 0.79
Preoperative risk factors for postoperative Clostridium difficile infection in colectomy patients. Am J Surg (2013) 0.79
Exploring risk factors for follicular lymphoma. Adv Hematol (2012) 0.79
New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy. Expert Rev Anticancer Ther (2015) 0.78
Temporal changes in plerixafor administration and hematopoietic stem cell mobilization efficacy: results of a prospective clinical trial in multiple myeloma. Biol Blood Marrow Transplant (2013) 0.78
Management Strategies for Elderly Patients with Diffuse Large B-Cell Lymphoma. Eur Oncol Haematol (2012) 0.78
Medicare policy and colorectal cancer screening: will changing access change outcomes? JAMA (2006) 0.78
A systematic literature review and meta-analysis of radioimmunotherapy consolidation for patients with untreated follicular lymphoma. Clin Lymphoma Myeloma Leuk (2012) 0.78
MLH1 promotor hypermethylation does not rule out a diagnosis of Lynch syndrome: a case report. Fam Cancer (2015) 0.77
A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma. Transfusion (2012) 0.77
Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma. Leuk Lymphoma (2014) 0.77
Idiotype vaccine strategies for treatment of follicular lymphoma. Future Oncol (2011) 0.77
ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II. Am J Clin Oncol (2016) 0.77
ACR Appropriateness Criteria: Localized nodal indolent lymphoma. Oncology (Williston Park) (2013) 0.76
Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma. Leuk Lymphoma (2011) 0.76
Racial differences in chronic lymphocytic leukemia. Digging deeper. Cancer (2013) 0.76
Management of relapsed chronic lymphocytic leukemia: applying guidelines to practice. Community Oncol (2012) 0.76
Clinical Practice Guideline for the Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula. Dis Colon Rectum (2016) 0.76
New Challenges in the Management of Diffuse Large B-Cell Lymphoma. Treat Strategies Hematol (2012) 0.75